WHITEHAWK THERAPEUTICS, INC.: 10-Q filed 2017-11-13

Name: WHITEHAWK THERAPEUTICS, INC.: 10-Q filed 2017-11-13
Creator: WHITEHAWK THERAPEUTICS, INC.

What WHITEHAWK THERAPEUTICS, INC. reported in its quarterly report filed 2017-11-13 (fiscal Q3 2017): 25 published measures, 66 facts as tagged in accession 0001564590-17-023441.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-11-13
Fiscal period: fiscal Q3 2017
Accession: 0001564590-17-023441 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All WHITEHAWK THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-09-30	26,001,610	USD
At 2016-12-31	2,396,878	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2017-09-30	23,415,377	USD
At 2016-12-31	-86,218,629	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2017-09-30	24,828,910	USD
At 2016-12-31	1,609,694	USD
At 2016-09-30	1,308,350	USD
At 2015-12-31	5,144,211	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-4,649,567	USD	92
2017-01-01 to 2017-09-30	-15,165,577	USD	273
2016-07-01 to 2016-09-30	-4,885,601	USD	92
2016-01-01 to 2016-09-30	-13,465,561	USD	274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	6,547	USD	273
2016-01-01 to 2016-09-30	113,297	USD	274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-09-30	-102,327,627	USD
At 2016-12-31	-86,218,753	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2017-09-30	116,873	USD
At 2016-12-31	149,595	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	127,359	USD	92
2017-01-01 to 2017-09-30	394,268	USD	273
2016-07-01 to 2016-09-30	113,498	USD	92
2016-01-01 to 2016-09-30	358,263	USD	274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-4,756,238	USD	92
2017-01-01 to 2017-09-30	-15,099,685	USD	273
2016-07-01 to 2016-09-30	-4,745,315	USD	92
2016-01-01 to 2016-09-30	-13,328,191	USD	274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-09-30	25,863,777	USD
At 2016-12-31	2,226,323	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-09-30	2,586,233	USD
At 2016-12-31	14,857,617	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2017-09-30	855,423	USD
At 2016-12-31	1,135,608	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2017-09-30	39,246	USD
At 2016-12-31	4,157	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	4,756,238	USD	92
2017-01-01 to 2017-09-30	15,099,685	USD	273
2016-07-01 to 2016-09-30	4,745,315	USD	92
2016-01-01 to 2016-09-30	13,328,191	USD	274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	2,942,170	USD	92
2017-01-01 to 2017-09-30	8,366,869	USD	273
2016-07-01 to 2016-09-30	3,481,261	USD	92
2016-01-01 to 2016-09-30	9,374,383	USD	274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-09-30	27,070,038	shares
At 2016-12-31	1,240,925	shares

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-4,649,567	USD	92
2017-01-01 to 2017-09-30	-16,108,874	USD	273
2016-07-01 to 2016-09-30	-5,940,258	USD	92
2016-01-01 to 2016-09-30	-16,339,486	USD	274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	1,814,068	USD	92
2017-01-01 to 2017-09-30	6,732,816	USD	273
2016-07-01 to 2016-09-30	1,264,054	USD	92
2016-01-01 to 2016-09-30	3,953,808	USD	274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	39,269	USD	273
2016-01-01 to 2016-09-30	53,244	USD	274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	997	USD	274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	106,671	USD	92
2017-01-01 to 2017-09-30	-65,892	USD	273
2016-07-01 to 2016-09-30	-140,286	USD	92
2016-01-01 to 2016-09-30	-137,370	USD	274

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	0	USD	273
2016-01-01 to 2016-09-30	0	USD	274

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	0	USD	273
2016-01-01 to 2016-09-30	0	USD	274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	40,247,775	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	35,089	USD	273
2016-01-01 to 2016-09-30	-109,399	USD	274

Inspect the source

Entity: WHITEHAWK THERAPEUTICS, INC. / CIK 0001422142
Captured: 2026-09-20T08:03:20.803Z
SEC response SHA-256: 0bc3518b433577b57088b38c087953d494e28bdd319b1da3b435ea8e7e18b0c1

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001422142.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))